The impact of vaccines for diarrhoea on antibiotic use among children in five low-resource settings: a comparative
Elizabeth T Rogawski McQuade1, Stephanie A Brennhofer2, Sarah E Elwood2
1Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Insights
Enteric vaccines could prevent 8-12 antibiotic courses per 100 children annually. Combination vaccines are key to significantly reducing overall antibiotic use in low-resource settings.
Area of Science:
- Global Health
- Infectious Diseases
- Vaccinology
Background:
- Antibiotic resistance is a growing global health concern.
- Diarrhoeal diseases are a major cause of morbidity and mortality in low-resource settings.
- Antibiotic use for diarrhoea contributes to antimicrobial resistance.
Purpose of the Study:
- To quantify the potential impact of enteric vaccines on antibiotic use.
- To compare the effectiveness of single-pathogen versus combination vaccines in reducing antibiotic consumption.
- To model the effect of vaccines on antibiotic-treated diarrhoea and overall antibiotic exposure.
Main Methods:
- Analysis of a longitudinal birth cohort from five countries (Bangladesh, India, Nepal, Pakistan, Tanzania).
- Monte Carlo simulations to model nine vaccination scenarios (six single, three combination vaccines).
- Estimation of reductions in antibiotic-treated diarrhoea, overall antibiotic courses, and bystander pathogen exposures.
Main Results:
- A Shigella vaccine showed the greatest reduction in antibiotic courses for all-cause diarrhoea (-8.2 courses per 100 child-years).
- An adenovirus-norovirus-rotavirus vaccine demonstrated the largest reduction in antibiotic use among combination vaccines (-12.2 courses per 100 child-years).
- Projected vaccine impact on antibiotic use in 2021 was 45-74% lower than in 2009-12 due to decreased diarrhoea incidence.
Conclusions:
- Enteric vaccines hold promise for reducing antibiotic use, potentially preventing 8-12 courses per 100 children annually.
- Combination vaccines are likely necessary to achieve substantial reductions (greater than 1%) in total antibiotic use.
- The impact of vaccines on antibiotic use may be diminished by declining diarrhoea incidence over time.
Background:
Vaccines for diarrhoea could have the ancillary benefit of preventing antibiotic use. We aimed to quantify and compare the expected impact of enteric vaccines on antibiotic use via Monte Carlo simulations.
Methods:
We analysed data from a longitudinal birth cohort, which enrolled children from 2009 to 2012 from Bangladesh, India, Nepal, Pakistan, and Tanzania. We used Monte Carlo simulations to estimate hypothetical vaccine impact in nine vaccination scenarios (including six single vaccines and three combination vaccines) on antibiotic- treated diarrhoea, overall antibiotic courses, and antibiotic exposures to bystander pathogens. For each vaccine scenario, we randomly selected target pathogen-specific diarrhoea episodes to be prevented according to the specified vaccine efficacy and estimated the absolute and relative differences in incidence of antibiotic use outcomes between vaccine and no vaccine scenarios.
Findings:
Among 1119 children, there were 3029 (135·3 courses per 100 child-years) antibiotic-treated diarrhoea episodes. Based on simulated results, a Shigella vaccine would cause the greatest reductions compared with the other single pathogen vaccines in antibiotic courses for all-cause diarrhoea (6·1% relative reduction; -8·2 courses per 100 child-years [95% CI -9·4 to -7·2]), antibiotic courses overall (1·0% relative reduction; -8·2 courses per 100 child-years [-9·4 to -7·2]), and antibiotic exposures to bystander pathogens (1·2% relative reduction; -15·9 courses per 100 child-years [-18·5 to -13·8]). An adenovirus-norovirus-rotavirus vaccine would cause the greatest reductions in antibiotic use (12·2 courses per 100 child-years [-13·7 to -11·0]) compared with the other combination vaccines. However, projected vaccine effects on antibiotic use in 2021 were 45-74% smaller than those estimated in 2009-12 accounting for reductions in diarrhoea incidence in the past decade.
Interpretation:
Vaccines for enteric pathogens could result in up to 8-12 prevented courses of antibiotics per 100 vaccinated children per year. Combination vaccines will probably be necessary to achieve greater than 1% reductions in total antibiotic use among children in similar low-resource settings.
Funding:
Wellcome Trust and Bill & Melinda Gates Foundation.
Related Concept Videos
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
01:20Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
01:29Microorganisms in Medicine and Therapeutics
01:51Vaccinations
01:17Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
00:57Antibiotic Selection